George B. Breen, Member of the Firm in the Health Care and Life Sciences and Litigation practices and Chair of the firm’s National Health Care and Life Sciences Practice Steering Committee, in the firm’s Washington, DC, office, was quoted in the Bloomberg BNA Health Care Daily Report, in “Medicare False Claims Appeal Filing Presses Novel Defense,” by Matt Phifer. (Read the full version – subscription required.)

Following is an excerpt:

A federal appeals court is being asked to dismiss a False Claims Act case against a nursing home chain based on a novel argument: The whistleblower sold some of her interest in the case’s outcome to finance it.

Although third-party financing arrangements are routine in federal court litigation, attorneys representing Consulate Health Care are arguing former nurse Angela Ruckh’s decision to sell some or all of what she may recover if her claims succeed is more than a simple fee arrangement, violates the FCA, and may be suspect under the U.S. Constitution.

The motion, filed with the U.S. Court of Appeals for the Eleventh Circuit, seeks dismissal of an appeal that could be worth more than $300 million. If the appeals court accepts the arguments, it could have major implications for false claims litigation by changing how FCA cases are litigated, including what money may be recoverable and even what evidence is discoverable.

“It’s the first time I can recall that there’s been an effort made from a defense perspective to effectively seek dismissal because the relator has contracted with one of these litigation funding organizations as part of its effort to prosecute the case,” George Breen, a partner at Epstein Becker Green in Washington, said. …

Breen told Bloomberg Law the case raises questions about to whom a defendant is obligated to pay recoveries because the statute envisions recoveries being paid to relators, not third-party litigation financiers. “Are those expenses—if you ever engage in a relationship with a litigation funding source, and it’s paying for your fees and costs—are those recoverable from a defendant?”

Breen also pointed out that a relationship between a relator and a financing company is not an attorney-client relationship. “That opens the door for discovery,” Breen told Bloomberg Law. “What did the relator share with the third-party funding source?”

He explained that such information, if discovered, could undermine the relator’s case by revealing strategy as well as the relator’s thought processes with respect to the strengths and weaknesses of their case.

Jump to Page

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Performance Cookies

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.